Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for ...
ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
NEW ORLEANS -- Two poster sessions that spanned 4 days of the American Academy of Ophthalmology meeting provided new data about the natural history and management of age-related macular degeneration ...
Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration. In the second part of her Q&A with The American Journal of Managed Care ®, Julie ...
- Data demonstrating that Ixo-vec was generally well tolerated and that a single intravitreal (IVT) injection can lead to stable and persistent aflibercept protein levels through three years in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results